Speaker:

Daryl J. Kor, MD  

Consultant, Department of Anesthesiology, Mayo Clinic

Consultant, Division of Central Anesthesiology, Department of Anesthesiology, Mayo Clinic, Rochester, Minnesota

Consultant (Joint Appointment) Division of Intensive Care and Respiratory Care, Department of Anesthesiology, Mayo Clinic, Rochester, Minnesota

Associate Professor of Anesthesiology, Mayo Clinic College of Medicine

Master’s Faculty Privileges in Clinical and Translational Science, Mayo Graduate School, Mayo Clinic College of Medicine

Medical Director, Clinical Informatics Program, Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Rochester, Minnesota

Medical Director, Information Management Program, Office of Information and Knowledge Management, Rochester, Minnesota

Objectives: 

• Describe the epidemiology of blood component utilization
• Identify evidence (or lack thereof) for transfusion efficacy
• Recognize potential risks associated with transfusion therapies
• Recognize opportunities for improvement in our current transfusion practice

Locations:    

• Mayo Clinic Building, Taylor Auditorium
• Mayo Clinic Hospital, MCH Waugh Auditorium Side B (MCH 1-220B)
• Mayo Clinic Women’s Health Internal Medicine
• Mayo Clinic Family Medicine – Arrowhead
• Kingman Regional Medical Center
• Yuma Regional Medical Center
• Canyon Ranch Medical Center
• Mayo Clinic Primary Care – San Tan

ALL PHYSICIANS AND ALLIED STAFF ARE WELCOME

**NEW** ATTENDANCE REQUIREMENT 
A unique presentation code must be sent via text to 507-200-3010 
to record attendance and to ensure you receive CME credit for your attendance.  
NOTE:  Attendees must be present to receive code.  

FACULTY DISCLOSURE

As a provider accredited by Accreditation Council on Continuing Medical Education (ACCME), Mayo Clinic College of Medicine, must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of these relevant financial relationships is included course materials so participants may formulate their own judgments regarding the presentation.